Skip to content

Scailyte & CHU Rennes announce Covid-19 partnership

Scailyte CHU Rennes announce Covid-19 partnership. Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 3.1 million in a pre-Series A round led by Swisscom Ventures.

Scailyte AG was founded in Luzern, Switzerland in July 2017. Scailyte is an ETH Zurich spin-off and is supported by Innosuisse (Swiss Innovation Agency). The company has gained recognition by winning several national and international start-up competitions, and is the beneficiary of significant research grants. Scailyte has a multi-disciplinary team with expertise in Cell biology, Genetics, Artificial Intelligence, Software development, Finance, Marketing and Sales.

The ScaiVision™ biomarker discovery platform delivers best-in-class performance for supervised
pattern recognition analysis of single-cell data. The performance and clinically-relevant application of the core deep learning algorithm of ScaiVision have been validated in several scientific papers and
have resulted in patent-pending diagnostic applications. For more information visit www.scailyte.com

Scailyte™ and ScaiVision™ are registered trademarks proprietary to Scailyte AG.

Recent News

NextGen Omics Boston Conference

Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31

Read more

Recent News

Vijay Tiwari is appointed as Chair of the Scientific Advisory Board

Vijay Tiwari is appointed as the Chair of Scailyte's Scientific Advisory Board

Read more

Recent News

Endometriosis interview series

We mark Endometriosis Awareness Month, and Scailyte is proud to support this cause with the “Endom

Read more

Recent News

Scailyte Announces a Collaboration with Turnstone Biologics

Scailyte Announces Collaboration with Turnstone Biologics to Identify Biomarker Signatures in Solid

Read more

Recent News

BIO-Europe Spring 2023

We will be attending the 17th annual BIO-Europe Spring taking place from 20-22 March 2023 in Basel.

Read more

Recent News

Deciphering Disease Mechanisms Through Functional Genomics

Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica

Read more

Recent News

International Women's Day 2023

Scailyte celebrates International Women’s day and praises all women Scailyters: smart, trailblazin

Read more

Recent News

Diana Stoycheva and Sarah Carl at Biomarkers 2023

We are excited to announce our attendance at Oxford Global Conferences' Biomarkers 2023! Our team, i

Read more

Recent News

01 /04

NextGen Omics Boston Conference

Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31

Read more

Vijay Tiwari is appointed as Chair of the Scientific Advisory Board

Vijay Tiwari is appointed as the Chair of Scailyte's Scientific Advisory Board

Read more

Recent News

02 /04

Endometriosis interview series

We mark Endometriosis Awareness Month, and Scailyte is proud to support this cause with the “Endom

Read more

Scailyte Announces a Collaboration with Turnstone Biologics

Scailyte Announces Collaboration with Turnstone Biologics to Identify Biomarker Signatures in Solid

Read more

Recent News

03 /04

BIO-Europe Spring 2023

We will be attending the 17th annual BIO-Europe Spring taking place from 20-22 March 2023 in Basel.

Read more

Deciphering Disease Mechanisms Through Functional Genomics

Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica

Read more

Recent News

04 /04

International Women's Day 2023

Scailyte celebrates International Women’s day and praises all women Scailyters: smart, trailblazin

Read more

Diana Stoycheva and Sarah Carl at Biomarkers 2023

We are excited to announce our attendance at Oxford Global Conferences' Biomarkers 2023! Our team, i

Read more

Recent News